Press Releases March 26, 2026 06:30 AM

BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026

KANZHUN LIMITED intensifies share repurchase program with over RMB480 million deployed in 2026

By Avery Klein BZ
BOSS Zhipin Repurchases 748,460 Shares; Total Repurchases Amount to Over RMB480 Million in 2026
BZ

KANZHUN LIMITED, trading as BOSS Zhipin on Nasdaq, announced ongoing execution of its share repurchase program, spending approximately RMB34.4 million to buy back 748,460 ordinary shares on March 25, bringing total repurchases in 2026 to over RMB480 million. This action reflects the company's commitment to enhance shareholder value.

Key Points

  • KANZHUN LIMITED repurchased 748,460 shares using RMB34.4 million on March 25, 2026.
  • Total share repurchases in 2026 have surpassed RMB480 million.
  • The repurchase program signals strong commitment to shareholder returns and confidence in company valuation.

BEIJING, March 26, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing around RMB34.4 million to repurchase 748,460 ordinary shares on March 25. Year-to-date in 2026, the Company has deployed over RMB480 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns.


Risks

  • Future share price volatility may affect the company's market capitalization and repurchase impact.
  • Large capital allocation to buybacks may limit funds available for operational growth or strategic investments.
  • Market conditions or regulatory changes could influence future repurchase activities or company performance.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026